Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

Carcinogenicity testing is only required for wide dispersive use substances classified as a cat. 3 mutagen or substances that demonstrate hyperplasia or pre-neoplastic lesions in repeated dose studies.   Neither the linear alkylbenzenesulfonates, nor the hydrotropes, both of which are the consituents of the reaction product Marlon ARL, are mutagenic substance nor do they demonstrate such lesions in repeated dose studies, and thus do not meet requirements for carcinogenicity testing.  There are 2-year dermal assays with mice and rats for the hydrotropes and both are negative for carcinogenicity.  Up to 240 mg (rats) and 727 mg (mice) sodium xylenesulfonate/kg body weight in 50% ethanol were dosed 5 days per week for 104 weeks. There were no treatment related incidences of mononuclear cell leukenia, neoplasms, or nonneoplatic lesions of the skin and other organs. The increased incidence of epidermal hyperplasia may have been related to exposure to the test substance.  The NOAEL was reported as 240 mg/kg bw/day for rats and 727 mg/kg bw/day for mice.

Key value for chemical safety assessment

Carcinogenicity: via dermal route

Endpoint conclusion
Dose descriptor:
NOAEL
240 mg/kg bw/day

Justification for classification or non-classification

Non-carcinogenic. There was no evidence of carcinogenic activity of sodium xylenesulfonate in male or female rats or mice.

Additional information

50 male and 50 female rats and mice were administered dermal applications of up to 240 mg (rats) and 727 mg (mice) sodium xylenefulfonate/kg body weight in 50% ethanol. Doses were applied 5 days per week for 104 weeks to the clipped interscapular skin at volumes adjusted for the weights of the animals throughout the study. Animals were housed individually and fed and given water ad libitum. Cages were changed weekly and racks were rotated every 2 weeks. All animals were observed twice daily and clinical findings were recorded monthly. Body weights were recorded weekly for 13 weeks, then monthly thereafter. All animals were necropsied and a complete histopathological examination was performed. All organs and tissues including skin were examined for grossly visible lesions. Major tissues were examined microscopically and slides were evaluated by an independent quality laboratory in addition to the study laboratory pathologist. The study was conducted under GLPs from late 1990 to late 1992 at the Battelle Columbus Laboratories. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Technical Grade Sodium Xylenesulfonate in F344/N Rats and B6C3F1 Mice. NTP TR 464, June 1998. The study reliability is Klimisch 1.

Survival of the dosed males and females was similar to that of the control groups and consistent with historical controls.

Mean body weights of dosed males and females were similar to those of the controls throughout and there were no clinical findings considered treatment related in males. In female rats, clinical findings were limited to irritation at the site of application in one control, in 4 at 120 mg/kg bw and in 2 at 240 mg/kg bw. In mice, clinical finding were limited to irritation of the site of application in female conrols, and males and females at the 364 and 727 mg/kg bw doses. There were no treatment related incidences of mononuclear cell leukenia, neoplasms, or nonneoplatic lesions of the skin and other organs. The increased incidence of epidermal hyperplasia may have been related to exposure to the test substance.


Carcinogenicity: via dermal route (target organ): other: all gross lesions and masses